Trump Signs Order to Reclassify Cannabis in Major U.S. Drug Policy Shift. President Donald Trump has signed an executive order directing the reclassification of cannabis under U.S. federal law, marking the biggest shift in American drug policy in decades. The order asks the attorney general to move cannabis from Schedule I — the most restricted category — to Schedule III, alongside drugs like Tylenol with codeine. Cannabis would remain illegal at the federal level, but the change would allow broader medical research and ease tax restrictions on state-legal dispensaries. Trump said the move responds to long-standing requests, particularly from patients with cancer, seizure disorders, and veterans suffering from chronic pain. He compared cannabis to prescription painkillers that have medical uses but also serious risks. The order also calls for expanded access to CBD and further research into its real-world health effects. Advocacy groups praised the move as a fundamental shift, while some Republican lawmakers warned it could normalize drug use and pose health risks. Despite political resistance, public opinion remains largely supportive, with most Americans favoring marijuana legalization.